[1] Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013;10(9):542-552.
[2] Song G, Sharma AD, Roll GR, et al. MicroRNAs control hepatocyte proliferation during liver regeneration. 2010; 51(5):1735-1743.
[3] Castro RE, Ferreira DM, Zhang X, et al. Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. Am J Physiol Gastrointest Liver Physiol. 2010;299(4): G887-897.
[4] Shu JM, Betsy TK, Xia ZL, et al. Genomewide MicroRNA Down-Regulation as a Negative Feedback Mechanism in the Early Phases of Liver Regeneration. Hepatology. 2011;54(20): 609-619.
[5] Olthoff KM, Emond JC, Shearon TH, et al. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2015;21(1): 79-88.
[6] Song GW, LeeSG. Living donor liver transplantation. Curr Opin Organ Transplant. 2014;19(3):217-222.
[7] Li J, Liu J, Hou Y, et al. Surgical technique improvement for liver transplantation in rats using 30% small-for-size grafts. Zhongguo Zuzhi Gongcheng Yanjiu. 2011;15(18): 3341-3346.
[8] 刘静,李江,张升宁,等.改良法构建大鼠减体积肝移植模型[J].中国组织工程研究与临床康复组织,2010,13(18):1208-1210.
[9] 李立.大鼠肝移植图谱[M].北京:人民卫生出版社,2012.
[10] 姚爱华,浦立勇,李相成,等.大鼠30%小体积肝移植模型三种切肝方法的比较[J].世界华人消化杂志,2007,15(3):3479-3483.
[11] Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation. 1979;28(1):47-50.
[12] Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery. 1983;93(1 Pt 1): 64-69.
[13] Li C, Mi K, Wen TF, et al. Safety of patients with a graft to body weight ratio less than 0.8% in living donor liver transplantation using right hepatic lobe without middle hepatic vein. Hepatogastroenterology. 2012;59(114):469-472.
[14] Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 2011;176:2-13.
[15] Dirsch O, Li J, He Q, et al. Induction of rejection after small-for-size liver transplantation: size matters. J Invest Surg. 2008;21(5):288-298.
[16] Raschzok N, Werner W, Sallmon H, et al. Temporal expression profiles indicate a primary function for microRNA during the peak of DNA replication after rat partial hepatectomy. Am J Physiol Regul Integr Comp Physiol. 2011;300:1363-1372.
[17] Zhou J, Ju W, Wang D, et al. Down-Regulation of microRNA-26a Promotes Mouse Hepatocyte Proliferation during Liver Regeneration. PLoS One. 2012;7(4):e33577.
[18] Kren BT, Wong PY, Shiota A, et al. Polysome trafficking of transcripts and microRNAs in regenerating liver after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol. 2009; 297:1181-1192.
[19] Marquez RT, Wendlandt E, Galle CS, et al. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1,and inhibits NF-kappa B signaling. Am J Physiol Gastrointest Liver Physiol. 2010; 298(4):G535-G541.
[20] Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol. 2008;18(10):505-516.
[21] Ng R, Song G, Roll GR, et al. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest. 2012;122(3):1097-1108.
[22] Pineau P, Volinia S, McJunkin K, et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Nat Acad Sci USA. 2010;107:264-269.
[23] Chen H, Sun Y, Dong R, et al. mir-34a is upregulated during liver regeneration in rats and is associated with the suppression of hepatocyte proliferation. PLoS One. 2011;6(5): e20238.
[24] Jiang W, Kong L, Ni Q, et al. miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6. PLoS One. 2014;9(7):e101530.
[25] Chen Q, Kong L, Xu X, et al. Down-regulation of microRNA-146a in the early stage of liver ischemia-reperfusion injury. Transplant Proc. 2013;45:492-496.
[26] Jiang W, Kong L, Ni Q, et al. miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6. PLoS One. 2014;9(7):e101530.
[27] Li H, Sun Q, Han B, et al. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2. Int J Clin Exp Pathol. 2015;8(5):4782-4790.
[28] Roderburg C, Trautwein C, Luedde T, et al. microrna-199a/b-3p: a new star in the liver microcosmos. Hepatology. 2011;54(2):729-731.
[29] Henry JC, Park JK, Jiang J, et al. mir-199a-3p targets cd44 and reduces proliferation of cd44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2010; 403(1):120-125.
[30] Jia XQ, Cheng HQ, Qian X, et al. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma. Cell Biochem Biophys. 2012;62(1):237-244.
[31] Du JY, Wang LF, Wang Q, et al. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2, 6- bisphosphatase-3 driven glycolysis in osteosarcoma cells. Oncol Rep. 2015;33(4):1890-1898. |